CEACAM1 and Hepatic steatosis: Mice with hepatocytes-specific deletion (AlbCre+Cc1fl/fl) or inactivation (L-SACC1) of Ceacam1 provide an in vivo demonstration that hepatic inflammation and fibrosis can be associated with visceral obesity, insulin resistance, and hepatic steatosis.